Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare-Reference-Cited by-同舟云学术

Comparative Risk of Hospitalized Infection Associated With Biologic Agents in Rheumatoid Arthritis Patients Enrolled in Medicare

Published:2015-12-23 Issue:1 Volume:68 Page:56-66
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Yun Huifeng¹,Xie Fenglong¹,Delzell Elizabeth¹,Levitan Emily B.¹,Chen Lang¹,Lewis James D.²,Saag Kenneth G.¹,Beukelman Timothy¹,Winthrop Kevin L.³,Baddley John W.¹,Curtis Jeffrey R.¹

Affiliation:

1. University of Alabama at Birmingham

2. University of Pennsylvania; Philadelphia

3. Oregon Health & Science University; Portland

Funder

Agency for Healthcare Research and Quality

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.39399/fullpdf

Reference48 articles.

1. The risk of infections with biologic therapies for rheumatoid arthritis;Furst;Semin Arthritis Rheum,2010

2. Use of biologics in rheumatoid arthritis: current and emerging paradigms of care;Curtis;Clin Ther,2011

3. Overview of safety of non-biologic and biologic DMARDs;Ruderman;Rheumatology (Oxford),2012

4. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial;Keystone;Arthritis Rheum,2004

5. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial;St.Clair;Arthritis Rheum,2004

Cited by 138 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of biological and targeted synthetic basic anti-inflammatory drugs in elderly patients with rheumatoid arthritis: for or against;Problems of Geroscience;2024-06-30

2. Prevalence and Factors Associated with De-escalation of Anti-TNFs in Older Adults with Rheumatoid Arthritis: A Medicare Claims-Based Observational Study;Drugs & Aging;2024-06-20

3. Increased risk of cardiovascular events under the treatments with Janus kinase inhibitors versus biological disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a retrospective longitudinal population-based study using the Japanese health insurance database;RMD Open;2024-06

4. A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis;Expert Opinion on Drug Safety;2024-05-23

5. Clinical practice guidelines for the early detection, diagnosis, treatment, and follow-up of patients with rheumatoid arthritis. Colombian Association of Rheumatology, 2022;Revista Colombiana de Reumatología (English Edition);2024-04